Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Lisata Therapeutics, Inc. (LSTA) had Consolidated Net Income/Loss of $-4.49M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.49M |
|
-- |
|
-- |
|
$4.94M |
|
$-4.94M |
|
$0.07M |
|
$-4.88M |
|
$-4.88M |
|
$-4.49M |
|
$-4.49M |
|
|
Consolidated Net Income/Loss |
$-4.49M |
$-4.49M |
|
$-4.94M |
|
$-4.94M |
|
9.01M |
|
9.01M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$14.02M |
|
$0.02M |
|
$0.04M |
|
$14.06M |
|
$3.31M |
|
-- |
|
$0.07M |
|
$3.39M |
|
$10.67M |
|
$10.67M |
|
$10.67M |
|
9.11M |
|
| Cash Flow Statement Financials | |
$-3.08M |
|
-- |
|
$0.18M |
|
$15.96M |
|
$13.06M |
|
$-2.90M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.06% |
|
-42.06% |
|
-31.93% |
|
-42.06% |
|
$1.17 |
|
$-0.34 |
|
$-0.34 |
|